CONMED Corporation
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from CONMED Corporation's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Debt Due Cover Ratio: Debt due within a year is covered 239.7 times by its yearly operating cash. Higher than almost all Healthcare companies in United States.
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 8.9 times. Higher than 94% of Healthcare companies in United States.
- Cash Cushion Ratio: Debt, after subtracting cash, equals 54% of its market value (net debt). Lower than 92% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$190Over the last 3 years, every $100 of reported profit came with $190 of operating cash.
Higher than 73% of Healthcare companies in United States.
Self-Funding Ratio
8.9×Over the last 3 years its own operating cash covered its investment spending (capex) 8.9 times.
Higher than 94% of Healthcare companies in United States.
Cash Locked Ratio
$37For every $100 of sales, $37 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $43 tied up three years earlier.
More money tied up than 78% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
$39Sales grew 31% in 3 years; of every extra $100 of sales, $39 became extra profit.
Higher than 63% of Healthcare companies in United States.
Asset Productivity Ratio
+31% / +1%In 3 years sales changed by +31% while total assets changed by +1%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
239.7×Debt due within a year is covered 239.7 times by its yearly operating cash.
Higher than almost all Healthcare companies in United States.
Cash Cushion Ratio
−54%Debt, after subtracting cash, equals 54% of its market value (net debt).
Lower than 92% of Healthcare companies in United States.
Tangible Assets Ratio
40%Of every $100 the company owns, $40 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 88% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 83% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
CONMED Corporation owes $0.55 for every $1 it owns. Net profit fell 64% in the year to Dec 2025.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
26.7Investors pay $26.7 for every $1 of CONMED Corporation's yearly profit, lower than 51% of Healthcare companies in United States.
P/B ratio
1.42The share price is 1.42 times CONMED Corporation's book value per share, lower than 69% of Healthcare companies in United States.
Market cap
$1.5 BThe total market value of all of CONMED Corporation's shares at today's price (share price × number of shares), larger than 69% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$1.0 BWhat CONMED Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$34.77Net worth divided by the number of shares. The share price of $49.44 is 1.4 times this, which is the P/B above.
Return on equity (ROE)
5.5%CONMED Corporation earned 5.5% on its shareholders' money over the last year, higher than 80% of Healthcare companies in United States.
Owes vs Owns
0.55×CONMED Corporation owes $0.55 for every $1 it owns (moderate), higher than 60% of Healthcare companies in United States.
Dividend yield
NoneCONMED Corporation does not currently pay a dividend.
Revenue growth
+5%Revenue rose 5% in the year to Dec 2025, and grew 10% a year on average over 3 years.
Profit growth
-64%Net profit fell 64% in the year to Dec 2025.
Profit margin
3.4%CONMED Corporation keeps $3 of every $100 of revenue as net profit.
Cash quality
3.6×Cash from CONMED Corporation's business was 3.6× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
3.3×CONMED Corporation's operating profit covered its interest costs 3.3 times in the year to Dec 2025.
Cash vs debt
Net debtCONMED Corporation had $794 M more debt than cash (net debt) at Dec 2025.
Questions
What is CONMED Corporation's P/E ratio?
Investors pay $26.7 for every $1 of CONMED Corporation's yearly profit, lower than 51% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For CONMED Corporation: $1.5 B ÷ $1.0 B (30 Jun 2026) = 1.4.
What is CONMED Corporation's return on equity?
CONMED Corporation earned 5.5% on its shareholders' money over the last year, higher than 80% of Healthcare companies in United States.
How much does CONMED Corporation owe compared with what it owns?
CONMED Corporation owes $0.55 for every $1 it owns (moderate), higher than 60% of Healthcare companies in United States.
Does CONMED Corporation pay a dividend?
No. CONMED Corporation does not currently pay a dividend.
Is CONMED Corporation's revenue growing?
Revenue rose 5% in the year to Dec 2025, and grew 10% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.